Strategic Communication and Public Relations

Succession of DKFZ Chairman and Scientific Director open

Wolfgang Wick to remain at Heidelberg University Hospital

No. 33 | 14/07/2015 | by Sel

Heidelberg University Hospital and the German Cancer Research Center have announced that, following a short period of negotiations, the Medical Director of the Department of Neurology at Heidelberg University Hospital, Professor Dr. Wolfgang Wick, will no longer be assuming the position of Chairman and Scientific Member of the Management Board of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).

© dkfz.de

“We regret that Wolfgang Wick will not be taking over the position of Chairman and Scientific Director at the German Cancer Research Center,” said the Members of the DKFZ Management Board, Professor Otmar D. Wiestler (Chairman and Scientific Director) and Professor Josef Puchta (Administrative-Commercial Director).

“Professor Wick will further expand the National Center for Tumor Diseases. For this important role, it is essential that he continues his work in clinically oriented research,” says Professor Dr. Guido Adler, Chief Medical Director and Chairman of the Board of Heidelberg University Hospital. “We are pleased that our neurologist and excellent researcher, still in the early phases of his position in the Neurology Department, will stay at our hospital,” commented Professor Dr. Wolfgang Herzog, Dean of the Medical Faculty at Heidelberg University.

“Through his collaboration with the NCT and as head of a Clinical Cooperation Unit of DKFZ and Heidelberg University Hospital, he will continue to be closely linked with cancer research at the DKFZ,” said Wiestler with an optimistic look into the future. 

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.

Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Tumour Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS